comparemela.com

Latest Breaking News On - Human immunology biosciences inc - Page 5 : comparemela.com

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

Germany
United-states
United-kingdom
Planegg
Bayern
Massachusetts
Boston
China
South-korea
Canada
Jean-paul-kress
Janssen-biotech-inc

MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Germany
Boston
Massachusetts
United-states
Planegg
Bayern
Julia-neugebauer
Myles-clouston
Exchange-commission
Linkedin
Twitter
Human-immunology-biosciences-inc

MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Germany
Boston
Massachusetts
United-states
Canada
United-kingdom
Planegg
Bayern
Kaitlyn-nealy
Thomas-biegi
Julia-neugebauer
Jean-paul-kress

Ad hoc: MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance f

MorphoSys AG / Key word(s): Change in ForecastAd hoc: MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 202226-Jul-2022 / 11:10 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Gr.

Germany
Boston
Massachusetts
United-states
Planegg
Bayern
Julia-neugebauer
Myles-clouston
Exchange-commission
Linkedin
Twitter
Human-immunology-biosciences-inc

MorphoSys AG: MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

Preliminary Q2 2022 Monjuvi U.S. net product sales of US$ 23.3 million (€ 21.7 million)Update of financial guidance range for 2022 Monjuvi U.S. net product sales (now US$ 90 to US$ 110 million)Update of

Germany
Boston
Massachusetts
United-states
Canada
United-kingdom
Planegg
Bayern
Kaitlyn-nealy
Thomas-biegi
Julia-neugebauer
Jean-paul-kress

vimarsana © 2020. All Rights Reserved.